Porosity of the wall of a Neurolac® nerve conduit hampers nerve regeneration

One way to improve nerve regeneration and bridge longer nerve gaps may be the use of semipermeable/porous conduits. With porosity less biomaterial is used for the nerve conduit. We evaluated the short‐term effects of porous Neurolac® nerve conduits for in vivo peripheral nerve regeneration. In 10 male Black Hooded rats, a gap of 10 mm was bridged by a porous Neurolac® nerve conduit. Evaluation point ranged from 3 to 12 weeks. The sciatic nerve function was not measurable due to automutilation and flexion contractures. The gait‐stance duration showed no improvement with time, indicating a disturbed walking pattern. The nerve guides showed very fast degradation with swelling, fragmentation, and collapse. Furthermore, a severe foreign body reaction occurred. Nerve regeneration was severely hampered. This study showed no beneficial effects of porous Neurolac® nerve conduits when compared with previous findings with nonporous copolymeric nerve guides of a slightly different composition. © 2009 Wiley‐Liss, Inc. Microsurgery, 2009.

[1]  Shih-Kuang Hsu,et al.  Effects of unidirectional permeability in asymmetric poly(DL-lactic acid-co-glycolic acid) conduits on peripheral nerve regeneration: an in vitro and in vivo study. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[2]  S. Mackinnon,et al.  The Role of Conduits in Nerve Repair: A Review , 1996, Reviews in the neurosciences.

[3]  Jianwei Hou,et al.  Acceleration effect of basic fibroblast growth factor on the regeneration of peripheral nerve through a 15-mm gap. , 2003, Journal of biomedical materials research. Part A.

[4]  P H Robinson,et al.  Light-microscopic and electron-microscopic evaluation of short-term nerve regeneration using a biodegradable poly(DL-lactide-epsilon-caprolacton) nerve guide. , 1996, Journal of biomedical materials research.

[5]  A Gramsbergen,et al.  Biodegradable p(DLLA‐ϵ‐CL) nerve guides versus autologous nerve grafts: Electromyographic and video analysis , 2001, Muscle & nerve.

[6]  D. Grijpma,et al.  In vivo and in vitro degradation of poly[50/50 (85/15L/D)LA/ε-CL], and the implications for the use in nerve reconstruction , 2000 .

[7]  Joyce Evans,et al.  Gait-stance duration as a measure of injury and recovery in the rat sciatic nerve model , 1994, Journal of Neuroscience Methods.

[8]  R. Coggeshall,et al.  Permeable tubes increase the length of the gap that regenerating axons can span , 1987, Brain Research.

[9]  J. M. Schakenraad,et al.  A new PLLA/PCL copolymer for nerve regeneration , 1993 .

[10]  W. D. den Dunnen,et al.  Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(DL-lactide-epsilon-caprolactone). , 1997, Journal of biomedical materials research.

[11]  P H Robinson,et al.  [A degradable artificial nerve guide to bridge peripheral nerve defects]. , 2003, Nederlands tijdschrift voor geneeskunde.

[12]  S. Mackinnon,et al.  Functional Evaluation of Complete Sciatic, Peroneal, and Posterior Tibial Nerve Lesions in the Rat , 1989, Plastic and reconstructive surgery.

[13]  A. Gramsbergen,et al.  Long-term reinnervation effects after sciatic nerve lesions in adult rats. , 2005, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[14]  P H Robinson,et al.  Poly(DL‐lactide‐ϵ‐caprolactone) nerve guides perform better than autologous nerve grafts , 1996, Microsurgery.

[15]  M. Meek,et al.  US Food and Drug Administration/Conformit Europe-Approved Absorbable Nerve Conduits for Clinical Repair of Peripheral and Cranial Nerves , 2008, Annals of plastic surgery.

[16]  M. Meek,et al.  Clinical Use of Nerve Conduits in Peripheral-Nerve Repair: Review of the Literature , 2002, Journal of reconstructive microsurgery.

[17]  P. M. Galletti,et al.  Blind-ended semipermeable guidance channels support peripheral nerve regeneration in the absence of a distal nerve stump , 1988, Brain Research.

[18]  D. Grijpma,et al.  High molecular weight copolymers of l-lactide and ε-caprolactone as biodegradable elastomeric implant materials , 1991 .